Prosecution Insights
Prosecution Insights
Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering
13 pending office actions • 3 clients • 12 examiners • 6 art units • 0 of 13 (0%) have an AI response strategy ready • 13 patents granted in the last 365 days
ARENTFOX SCHIFF LLP and CARDINAL HEALTH operates in the Biotechnology & Pharmaceuticals technology area, with 33493 career applications. This massive volume of work demonstrates extensive experience across the patent landscape. The firm is currently managing 8 pending office actions, indicating a focused active workload for this specific partnership.
The firm maintains a resolved allowance rate pct of 88.06, showing a high success rate across its large portfolio. Prosecution typically involves an avg office actions per allowance of 3.27. This average suggests that securing an allowance in Biotechnology & Pharmaceuticals often requires several rounds of negotiation with the USPTO.
The 88.06 resolved allowance rate pct across 33493 career applications underscores the firm's reliability as a large-scale prosecution partner. The 3.27 avg office actions per allowance provides a benchmark for clients expecting a thorough prosecution process. With 8 pending office actions, the firm continues to leverage its vast experience to achieve successful outcomes.
Based on the USPTO statutory response window for each pending office action. 6 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 6 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 7 (54%) |
| Double-patenting + other | 2 (15%) |
| Multi-statute (no §101) | 4 (31%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SAMALA, JAGADISHWAR RAO | 2 | 68.0% | +55.6% |
| PLAKKOOTTAM, DOMINICK L | 1 | 74.4% | +14.9% |
| RUSHING, MARK S | 1 | 76.7% | +23.6% |
| SHOULDERS, ANNIE LEE | 1 | 74.6% | +17.6% |
| WILDER, ANDREW H | 1 | 62.6% | +58.5% |
| DOUBRAVA, JOHN A | 1 | 76.9% | +26.4% |
| BOSWORTH, KAMI A | 1 | 69.1% | +28.7% |
| SHAH, NILAY J | 1 | 76.3% | +46.9% |
| MEDWAY, SCOTT J | 1 | 66.7% | +23.4% |
| LAU, JONATHAN S | 1 | 63.7% | -17.3% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18351905 | MANNOSYLATED AMINE DEXTRAN DRUG DELIVERY VEHICLES WITH DEGRADABLE DISULFIDE/CARBONATE LINKERS TARGETING PAYLOADS TO CD206 EXPRESSING CELLS | LAU, JONATHAN S | 83d |
| 18962578 | ECG ELECTRODE WITH RETENTION FEATURE | SHOULDERS, ANNIE LEE | — |
| 18460190 | ENTERAL FEEDING SYRINGE INSTALLATION AND DETECTION | SHAH, NILAY J | — |
| 18447698 | OCCLUSION DETECTION SYSTEM AND METHOD FOR A FLOW CONTROL APPARATUS | MEDWAY, SCOTT J | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18634290 | FILTERING CROSS READS AMONG RADIO FREQUENCY IDENTIFICATION (RFID) ENABLED READERS AND SYSTEMS AND METHODS FOR USE THEREOF | WILDER, ANDREW H | 409d overdue |
| 17039409 | COMPOSITIONS AND RELATED METHODS FOR BLOCKING OFF-TARGET LOCALIZATION OF MANNOSYLATED DEXTRANS AND OTHER CD206 LIGANDS | SAMALA, JAGADISHWAR RAO | 80d overdue |
| 18417250 | ADAPTER ASSEMBLY FOR ENTERAL FEEDING | DOUBRAVA, JOHN A | 39d |
| 19544675 | FLUID DELIVERY | PLAKKOOTTAM, DOMINICK L | — |
| 19233942 | REMOTE MONITORING OF ABSORBENT ARTICLE | RUSHING, MARK S | — |
| 18962578 | ECG ELECTRODE WITH RETENTION FEATURE | SHOULDERS, ANNIE LEE | — |
| 18492452 | CASSETTE FOR A FLOW CONTROL APPARATUS | BOSWORTH, KAMI A | — |
| 18460190 | ENTERAL FEEDING SYRINGE INSTALLATION AND DETECTION | SHAH, NILAY J | — |
| Client (Assignee) | Pending OAs |
|---|---|
| KPR U.S. | 7 |
| Cardinal Health | 5 |
| WAVEMARK, INC. | 1 |
| Art Unit | Apps |
|---|---|
| 3783 | 4 |
| 1618 | 3 |
| 3746 | 1 |
| 3627 | 1 |
| 1693 | 1 |
| 3791 | 1 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 19544675 | FLUID DELIVERY | Kpr U.S., LLC | PLAKKOOTTAM, DOMINICK L | 3746 | §112DP | Non-Final OA | — | Pending | Feb 19, 2026 |
| 19233942 | REMOTE MONITORING OF ABSORBENT ARTICLE | Kpr U.S., LLC | RUSHING, MARK S | §103 | Non-Final OA | — | Pending | Jun 10, 2025 | |
| 18962578 | ECG ELECTRODE WITH RETENTION FEATURE | Kpr U.S., LLC | SHOULDERS, ANNIE LEE | §102§103 | Non-Final OA | — | Pending | Nov 27, 2024 | |
| 18634290 | FILTERING CROSS READS AMONG RADIO FREQUENCY IDENTIFICATION (RFID) ENABLED READERS AND SYSTEMS AND METHODS FOR USE THEREOF | Wavemark, Inc. | WILDER, ANDREW H | 3627 | §103 | Final Rejection | 409d overdue | Pending | Apr 12, 2024 |
| 18417250 | ADAPTER ASSEMBLY FOR ENTERAL FEEDING | Kpr U.S., LLC | DOUBRAVA, JOHN A | 3783 | §103 | Non-Final OA | 39d | Pending | Jan 19, 2024 |
| 18492452 | CASSETTE FOR A FLOW CONTROL APPARATUS | Kpr U.S., LLC | BOSWORTH, KAMI A | 3783 | §103 | Final Rejection | — | Pending | Oct 23, 2023 |
| 18460190 | ENTERAL FEEDING SYRINGE INSTALLATION AND DETECTION | Kpr U.S., LLC | SHAH, NILAY J | 3783 | §102§103 | Non-Final OA | — | Pending | Sep 01, 2023 |
| 18447698 | OCCLUSION DETECTION SYSTEM AND METHOD FOR A FLOW CONTROL APPARATUS | Kpr U.S., LLC | MEDWAY, SCOTT J | 3783 | §102§103§112 | Non-Final OA | — | Pending | Aug 10, 2023 |
| 18351905 | MANNOSYLATED AMINE DEXTRAN DRUG DELIVERY VEHICLES WITH DEGRADABLE DISULFIDE/CARBONATE LINKERS TARGETING PAYLOADS TO CD206 EXPRESSING CELLS | Cardinal Health 414, LLC | LAU, JONATHAN S | 1693 | §102§103 | Non-Final OA | 83d | Pending | Jul 13, 2023 |
| 18189658 | Competitive Self-Blocking with Unlabeled Manocept Imaging Agents | Cardinal Health 414, LLC | VU, JAKE MINH | 1618 | §103 | Final Rejection | 12d | Pending | Mar 24, 2023 |
| 17576745 | METHODS OF USING AN ENHANCED THERAPEUTIC STIMULUS FOR NON-NUTRITIVE SUCK ENTRAINMENT SYSTEM | Cardinal Health 200, LLC | NGUYEN, HUONG Q | 3791 | §103 | Final Rejection | 8d overdue | Pending | Jan 14, 2022 |
| 17131087 | COMPOUNDS AND COMPOSITIONS FOR TARGETING MACROPHAGES AND OTHER MANNOSE-BINDING C-TYPE LECTIN RECEPTOR HIGH EXPRESSING CELLS AND METHODS OF TREATING AND DIAGNOSIS USING SAME | Cardinal Health 414, LLC | SAMALA, JAGADISHWAR RAO | 1618 | §103 | Final Rejection | — | Pending | Dec 22, 2020 |
| 17039409 | COMPOSITIONS AND RELATED METHODS FOR BLOCKING OFF-TARGET LOCALIZATION OF MANNOSYLATED DEXTRANS AND OTHER CD206 LIGANDS | Cardinal Health 414, LLC | SAMALA, JAGADISHWAR RAO | 1618 | §103DP | Final Rejection | 80d overdue | Pending | Sep 30, 2020 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial